True. The list of failures for numerous other ASX graphite stocks is equally impressive, although some of their share prices have held up surprisingly well.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025